1
|
Oba J, Toriya M, Uwamino Y, Matsuo K. Using a Systems Engineering Approach to Build a PCR Testing System at a Medical School During the COVID-19 Pandemic. Risk Manag Healthc Policy 2024; 17:649-662. [PMID: 38528942 PMCID: PMC10962361 DOI: 10.2147/rmhp.s441618] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2023] [Accepted: 02/16/2024] [Indexed: 03/27/2024] Open
Abstract
Background During the COVID-19 pandemic, there was an increasing need to expand diagnostic testing in hospitals. At Keio University Hospital (KUH), clinical staff were concerned that the demand for PCR testing might exceed the capacity of the Clinical Laboratory. In response, basic researchers at Keio University School of Medicine (KUSM) set out to build a new, collaborative, PCR testing system. To be authorized to perform such diagnostic PCR testing, KUSM registered its core laboratory as an external clinical laboratory (ECL). Methods In the pandemic, there was a pressure to build the PCR system quickly. Speed required discussions that developed a shared understanding of the unprecedented, new KUH/KUSM PCR system. To design, construct, and archive the new PCR testing system, we used a systems engineering (SE) approach. This included diagram visualization of functional flows and application of the Unified Architecture Framework (UAF), both of which are often used in system building. We considered daily demand for PCR testing at KUH and KUSM, and daily COVID-19 infections in Japan. Results We operated the collaborative PCR testing system from August 2020 to June 2022. Given public health insurance reimbursement policies, KUH focused on individuals with suspicious symptoms, while the ECL at KUSM screened samples from asymptomatic individuals. KUSM performed about half as many tests as KUH. Interviewing KUH staff revealed that diagrams helped promote a better understanding of the KUH/KUSM PCR testing system. Conclusion When designing temporary systems that may be repurposed in the future, we suggest using an SE approach with diagrams and UAF perspectives. This approach will enable stakeholders to understand what is being proposed to be built, and facilitate achieving an informed consensus on the proposed system. We suggest that SE approaches should be widely used in projects that involve building and operating complex, collaborative systems, and documenting the process.
Collapse
Affiliation(s)
- Junna Oba
- Department of Extended Intelligence for Medicine, the Ishii-Ishibashi Laboratory, Keio University School of Medicine, Tokyo, Japan
| | - Masako Toriya
- Global Research Institute, Keio University, Tokyo, Japan
| | - Yoshifumi Uwamino
- Department of Laboratory Medicine, Keio University School of Medicine, Tokyo, Japan
| | - Koichi Matsuo
- Collaborative Research Resources, Keio University School of Medicine, Tokyo, Japan
| |
Collapse
|
3
|
Wagner K, Fox P, Gordon E, Hahn W, Olsen K, Markham A, Buglewicz D, Selemenakis P, Lessard A, Goldstein D, Threatt A, Davis L, Miller-Dawson J, Stockett H, Sanders H, Rugh K, Turner H, Remias M, Williams M, Chavez J, Galindo G, Cialek C, Koch A, Fout A, Fosdick B, Broeckling B, Zabel MD. A multiplexed, paired-pooled droplet digital PCR assay for detection of SARS-CoV-2 in saliva. Sci Rep 2023; 13:3075. [PMID: 36813822 PMCID: PMC9944410 DOI: 10.1038/s41598-023-29858-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2022] [Accepted: 02/11/2023] [Indexed: 02/24/2023] Open
Abstract
In response to the SARS-CoV-2 pandemic, we developed a multiplexed, paired-pool droplet digital PCR (MP4) screening assay. Key features of our assay are the use of minimally processed saliva, 8-sample paired pools, and reverse-transcription droplet digital PCR (RT-ddPCR) targeting the SARS-CoV-2 nucleocapsid gene. The limit of detection was determined to be 2 and 12 copies per µl for individual and pooled samples, respectively. Using the MP4 assay, we routinely processed over 1,000 samples a day with a 24-h turnaround time and over the course of 17 months, screened over 250,000 saliva samples. Modeling studies showed that the efficiency of 8-sample pools was reduced with increased viral prevalence and that this could be mitigated by using 4-sample pools. We also present a strategy for, and modeling data supporting, the creation of a third paired pool as an additional strategy to employ under high viral prevalence.
Collapse
Affiliation(s)
- Kaitlyn Wagner
- Prion Research Center, Department of Microbiology, Immunology and Pathology, College of Veterinary Medicine and Biomedical Sciences, Fort Collins, USA
- Colorado State University, Fort Collins, CO, 80523, USA
| | - Phil Fox
- Prion Research Center, Department of Microbiology, Immunology and Pathology, College of Veterinary Medicine and Biomedical Sciences, Fort Collins, USA
- Colorado State University, Fort Collins, CO, 80523, USA
| | - Elizabeth Gordon
- Prion Research Center, Department of Microbiology, Immunology and Pathology, College of Veterinary Medicine and Biomedical Sciences, Fort Collins, USA
- Colorado State University, Fort Collins, CO, 80523, USA
| | - Westen Hahn
- Prion Research Center, Department of Microbiology, Immunology and Pathology, College of Veterinary Medicine and Biomedical Sciences, Fort Collins, USA
- Colorado State University, Fort Collins, CO, 80523, USA
| | - Kenzie Olsen
- Prion Research Center, Department of Microbiology, Immunology and Pathology, College of Veterinary Medicine and Biomedical Sciences, Fort Collins, USA
- Colorado State University, Fort Collins, CO, 80523, USA
| | - Alex Markham
- Prion Research Center, Department of Microbiology, Immunology and Pathology, College of Veterinary Medicine and Biomedical Sciences, Fort Collins, USA
- Colorado State University, Fort Collins, CO, 80523, USA
| | - Dylan Buglewicz
- Prion Research Center, Department of Microbiology, Immunology and Pathology, College of Veterinary Medicine and Biomedical Sciences, Fort Collins, USA
- Colorado State University, Fort Collins, CO, 80523, USA
| | - Platon Selemenakis
- Prion Research Center, Department of Microbiology, Immunology and Pathology, College of Veterinary Medicine and Biomedical Sciences, Fort Collins, USA
- Colorado State University, Fort Collins, CO, 80523, USA
| | - Avery Lessard
- Prion Research Center, Department of Microbiology, Immunology and Pathology, College of Veterinary Medicine and Biomedical Sciences, Fort Collins, USA
- Colorado State University, Fort Collins, CO, 80523, USA
| | - Daniella Goldstein
- Prion Research Center, Department of Microbiology, Immunology and Pathology, College of Veterinary Medicine and Biomedical Sciences, Fort Collins, USA
- Colorado State University, Fort Collins, CO, 80523, USA
| | - Alissa Threatt
- Prion Research Center, Department of Microbiology, Immunology and Pathology, College of Veterinary Medicine and Biomedical Sciences, Fort Collins, USA
- Colorado State University, Fort Collins, CO, 80523, USA
| | - Luke Davis
- Prion Research Center, Department of Microbiology, Immunology and Pathology, College of Veterinary Medicine and Biomedical Sciences, Fort Collins, USA
- Colorado State University, Fort Collins, CO, 80523, USA
| | - Jake Miller-Dawson
- Prion Research Center, Department of Microbiology, Immunology and Pathology, College of Veterinary Medicine and Biomedical Sciences, Fort Collins, USA
- Colorado State University, Fort Collins, CO, 80523, USA
| | - Halie Stockett
- Prion Research Center, Department of Microbiology, Immunology and Pathology, College of Veterinary Medicine and Biomedical Sciences, Fort Collins, USA
- Colorado State University, Fort Collins, CO, 80523, USA
| | | | - Kristin Rugh
- Prion Research Center, Department of Microbiology, Immunology and Pathology, College of Veterinary Medicine and Biomedical Sciences, Fort Collins, USA
- Colorado State University, Fort Collins, CO, 80523, USA
| | - Houston Turner
- Prion Research Center, Department of Microbiology, Immunology and Pathology, College of Veterinary Medicine and Biomedical Sciences, Fort Collins, USA
- Colorado State University, Fort Collins, CO, 80523, USA
| | - Michelle Remias
- Prion Research Center, Department of Microbiology, Immunology and Pathology, College of Veterinary Medicine and Biomedical Sciences, Fort Collins, USA
- Colorado State University, Fort Collins, CO, 80523, USA
| | - Maggie Williams
- Prion Research Center, Department of Microbiology, Immunology and Pathology, College of Veterinary Medicine and Biomedical Sciences, Fort Collins, USA
- Colorado State University, Fort Collins, CO, 80523, USA
| | - Jorge Chavez
- Prion Research Center, Department of Microbiology, Immunology and Pathology, College of Veterinary Medicine and Biomedical Sciences, Fort Collins, USA
- Colorado State University, Fort Collins, CO, 80523, USA
| | - Gabriel Galindo
- Prion Research Center, Department of Microbiology, Immunology and Pathology, College of Veterinary Medicine and Biomedical Sciences, Fort Collins, USA
- Colorado State University, Fort Collins, CO, 80523, USA
| | - Charlotte Cialek
- Prion Research Center, Department of Microbiology, Immunology and Pathology, College of Veterinary Medicine and Biomedical Sciences, Fort Collins, USA
- Colorado State University, Fort Collins, CO, 80523, USA
| | - Amanda Koch
- Prion Research Center, Department of Microbiology, Immunology and Pathology, College of Veterinary Medicine and Biomedical Sciences, Fort Collins, USA
- Colorado State University, Fort Collins, CO, 80523, USA
| | - Alex Fout
- Department of Statistics, Colorado State University, Fort Collins, CO, 80523, USA
- Colorado State University, Fort Collins, CO, 80523, USA
| | - Bailey Fosdick
- Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, USA
| | - Bettina Broeckling
- Prion Research Center, Department of Microbiology, Immunology and Pathology, College of Veterinary Medicine and Biomedical Sciences, Fort Collins, USA
- Colorado State University, Fort Collins, CO, 80523, USA
| | - Mark D Zabel
- Prion Research Center, Department of Microbiology, Immunology and Pathology, College of Veterinary Medicine and Biomedical Sciences, Fort Collins, USA.
- Colorado State University, Fort Collins, CO, 80523, USA.
| |
Collapse
|
4
|
Turcinovic J, Kuhfeldt K, Sullivan M, Landaverde L, Platt JT, Doucette-Stamm L, Hanage WP, Hamer DH, Klapperich C, Landsberg HE, Connor JH. Linking contact tracing with genomic surveillance to deconvolute SARS-CoV-2 transmission on a university campus. iScience 2022; 25:105337. [PMID: 36246573 PMCID: PMC9554197 DOI: 10.1016/j.isci.2022.105337] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/19/2022] [Revised: 08/12/2022] [Accepted: 10/10/2022] [Indexed: 11/26/2022] Open
Abstract
Contact tracing and genomic data, approaches often used separately, have both been important tools in understanding the nature of SARS-CoV-2 transmission. Linked analysis of contact tracing and sequence relatedness of SARS-CoV-2 genomes from a regularly sampled university environment were used to build a multilevel transmission tracing and confirmation system to monitor and understand transmission on campus. Our investigation of an 18-person cluster stemming from an athletic team highlighted the importance of linking contact tracing and genomic analysis. Through these findings, it is suggestive that certain safety protocols in the athletic practice setting reduced transmission. The linking of traditional contact tracing with rapid-return genomic information is an effective approach for differentiating between multiple plausible transmission scenarios and informing subsequent public health protocols to limit disease spread in a university environment.
Collapse
Affiliation(s)
- Jacquelyn Turcinovic
- Department of Microbiology, Boston University School of Medicine, Boston, MA 02118, USA
- National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA 02118, USA
- Program in Bioinformatics, Boston University, Boston, MA 02215, USA
| | - Kayla Kuhfeldt
- Student Health Services, Boston University, Boston, MA 02215, USA
| | - Madison Sullivan
- Student Health Services, Boston University, Boston, MA 02215, USA
| | - Lena Landaverde
- Department of Biomedical Engineering, Boston University, Boston, MA 02215, USA
- Precision Diagnostics Center, Boston University, Boston, MA 02215, USA
- BU Clinical Testing Laboratory, Research Department, Boston University, Boston, MA 02215, USA
| | - Judy T. Platt
- Student Health Services, Boston University, Boston, MA 02215, USA
| | - Lynn Doucette-Stamm
- BU Clinical Testing Laboratory, Research Department, Boston University, Boston, MA 02215, USA
| | - William P. Hanage
- Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA
| | - Davidson H. Hamer
- National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA 02118, USA
- Precision Diagnostics Center, Boston University, Boston, MA 02215, USA
- Department of Global Health, Boston University School of Public Health, Boston, MA 02118, USA
- Section of Infectious Disease, Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA
- Center for Emerging Infectious Disease Policy and Research, Boston University, Boston, MA 02118, USA
| | - Catherine Klapperich
- Department of Biomedical Engineering, Boston University, Boston, MA 02215, USA
- Precision Diagnostics Center, Boston University, Boston, MA 02215, USA
| | | | - John H. Connor
- Department of Microbiology, Boston University School of Medicine, Boston, MA 02118, USA
- National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA 02118, USA
- Program in Bioinformatics, Boston University, Boston, MA 02215, USA
- Center for Emerging Infectious Disease Policy and Research, Boston University, Boston, MA 02118, USA
| |
Collapse
|
5
|
Blake H, Somerset S, Mahmood I, Mahmood N, Corner J, Ball JK, Denning C. A Qualitative Evaluation of the Barriers and Enablers for Implementation of an Asymptomatic SARS-CoV-2 Testing Service at the University of Nottingham: A Multi-Site Higher Education Setting in England. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2022; 19:13140. [PMID: 36293719 PMCID: PMC9603241 DOI: 10.3390/ijerph192013140] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 09/03/2022] [Revised: 09/24/2022] [Accepted: 10/09/2022] [Indexed: 06/16/2023]
Abstract
Asymptomatic testing for SARS-CoV-2 RNA has been used to prevent and manage COVID-19 outbreaks in university settings, but few studies have explored their implementation. The aim of the study was to evaluate how an accredited asymptomatic SARS-CoV-2 testing service (ATS) was implemented at the University of Nottingham, a multi-campus university in England, to identify barriers and enablers of implementation and to draw out lessons for implementing pandemic response initiatives in higher education settings. A qualitative interview study was conducted with 25 ATS personnel between May and July 2022. Interviews were conducted online, audio-recorded, and transcribed. Participants were asked about their experience of the ATS, barriers and enablers of implementation. Transcripts were thematically analysed. There were four overarching themes: (1) social responsibility and innovation, (2) when, how and why people accessed testing, (3) impact of the ATS on the spread of COVID-19, and (4) lessons learned for the future. In establishing the service, the institution was seen to be valuing its community and socially responsible. The service was viewed to be broadly successful as a COVID-19 mitigation approach. Challenges to service implementation were the rapidly changing pandemic situation and government advice, delays in service accreditation and rollout to staff, ambivalence towards testing and isolating in the target population, and an inability to provide follow-up support for positive cases within the service. Facilitators included service visibility, reduction in organisational bureaucracy and red tape, inclusive leadership, collaborative working with regular feedback on service status, flexibility in service delivery approaches and simplicity of saliva testing. The ATS instilled a perception of early 'return to normality' and impacted positively on staff feelings of safety and wellbeing, with wider benefits for healthcare services and local communities. In conclusion, we identified common themes that have facilitated or hindered the implementation of a SARS-CoV-2 testing service at a university in England. Lessons learned from ATS implementation will inform future pandemic response interventions in higher education settings.
Collapse
Affiliation(s)
- Holly Blake
- School of Health Sciences, University of Nottingham, Nottingham NG7 2HA, UK
- NIHR Nottingham Biomedical Research Centre, Nottingham NG7 2UH, UK
| | - Sarah Somerset
- NIHR Nottingham Biomedical Research Centre, Nottingham NG7 2UH, UK
- School of Medicine, University of Nottingham, Nottingham NG7 2RD, UK
| | - Ikra Mahmood
- School of Health Sciences, University of Nottingham, Nottingham NG7 2HA, UK
- School of Medicine, University of Nottingham, Nottingham NG7 2RD, UK
| | - Neelam Mahmood
- School of Health Sciences, University of Nottingham, Nottingham NG7 2HA, UK
| | - Jessica Corner
- Executive Office, University of Nottingham, Nottingham NG7 2RD, UK
| | - Jonathan K. Ball
- School of Life Sciences, University of Nottingham, Nottingham NG7 2UH, UK
- Biodiscovery Institute, University of Nottingham, Nottingham NG7 2RD, UK
| | - Chris Denning
- School of Medicine, University of Nottingham, Nottingham NG7 2RD, UK
- Biodiscovery Institute, University of Nottingham, Nottingham NG7 2RD, UK
| |
Collapse
|